viracept การใช้
- Agouron said early clinical studies showed Viracept is safe for children.
- Viracept is the most recent protease inhibitor to enter the mix.
- However, Stocrin and Viracept do have valid patents in Brazil.
- And what should he do after Viracept is introduced by Agouron Pharmaceuticals?
- The same was true for an AZT / 3TC / Viracept combination.
- Viracept is easier to take, and seemingly has fewer side effects.
- Of all the protease inhibitors, Viracept probably has the best profile.
- Viracept ( nelfinavir )-- Agouron Pharmaceuticals Inc.
- He also said Roche planned to begin producing Viracept in Brazil in 2002.
- Agouron also released preliminary data today on the use of Viracept in other combinations.
- Agouron has not set a price for Viracept.
- Viracept, also called nelfinavir, is recommended to be taken with a meal.
- Roche will support Agouron to obtain rapid approval of Viracept in Europe and other countries.
- More recently, Agouron Pharmaceuticals Inc . won FDA approval for its protease inhibitor Viracept.
- The government plans to start production of the generic Viracept in January, he said.
- Agouron's Viracept causes diarrhea, although this appears to be controllable with common medications.
- Viracept can cause diarrhea and nausea.
- The patients hadn't taken any other protease inhibitor before their initial treatment with Viracept.
- The rise for the not-yet-profitable company is based largely on hopes for Viracept.
- Nine of the 12 patients showed little or no response to other drugs after switching from Viracept.
- ตัวอย่างการใช้เพิ่มเติม: 1 2 3